Physician profile
Bashar J Marji
NPI 1508804113
$8,104.08
in general payments reported to CMS, 2019-2025
21 companies · $602 in 2025
The $602 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.23 · 2020: $909 · 2021: $1,013 · 2022: $3,003 · 2023: $2,205 · 2024: $335 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,961 · Travel and Lodging: $1,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,961.23 |
| Travel and Lodging | $1,180.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,298.26 | 2019-2023 | Diamondback Peripheral, Emboshield Nav6 |
| Medtronic, INC. | $2,776.89 | 2021-2024 | Linq II, Micra, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $342.21 | 2022-2025 | |
| Biotronik INC. | $206.96 | 2020-2025 | Amvia Edge, Biomonitor |
| Kestra Medical Technology Services, INC. | $197.41 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $187.20 | 2022-2024 | Camzyos, Eliquis |
| Amgen INC. | $178.60 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.69 | 2022-2025 | Jardiance |
| Pfizer INC. | $134.77 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.98 | 2021-2025 | Lifevest |
| Cardiovascular Systems INC. | $111.68 | 2022-2023 | Diamondback Peripheral |
| Impulse Dynamics (USA) INC. | $65.73 | 2025 | Optimizer |
| Boston Scientific Corporation | $63.49 | 2024-2025 | Watchman Flx, Synergy |
| Astrazeneca Pharmaceuticals Lp | $61.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $47.15 | 2022-2023 | Xarelto |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $32.40 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Sanofi-Aventis U.S. LLC | $30.33 | 2022 | |
| Amryt Pharma Holdings Ltd | $28.64 | 2023 | Juxtapid |
| Edwards Lifesciences Corporation | $19.20 | 2022 | |
| Amarin Pharma, INC. | $14.80 | 2020 | |
| Ge Healthcare | $14.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Marji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.